Yasutoshi Koga

11.8k citations

204 papers · 8.8k indexed · 3 hit papers · h-index 41

Co-authors: Eric A. Schon Mercy M. Davidson Michael P. King Salvatore DiMauro Ikuya Nonaka Shuichi Yatsuga Michio Hirano Massimo Zeviani
Topics: Mitochondrial Function and Pathology (62 papers)Metabolism and Genetic Disorders (43 papers)Diamond and Carbon-based Materials Research (28 papers)
Cited by: Clinical Biochemistry Molecular Biology Aging
Journals: Nature New England Journal of Medicine Journal of the American Chemical Society
Partner nations: Japan United States Germany

In The Last Decade

Yasutoshi Koga

200 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial diseases

2016 1.0k citations Salvatore DiMauro, Michio Hirano et al. profile →
Mitochondrial DNA Deletions in Progressive External Ophthalmoplegia and Kearns-Sayre Syndrome

1989 746 citations Salvatore DiMauro, Ikuya Nonaka et al. profile →
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)

2000 702 citations Yasutoshi Koga, Ikuya Nonaka et al. profile →

Peers

Countries citing papers authored by Yasutoshi Koga

Since Specialization

Citations

This map shows the geographic impact of Yasutoshi Koga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasutoshi Koga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasutoshi Koga more than expected).

Fields of papers citing papers by Yasutoshi Koga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasutoshi Koga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasutoshi Koga. The network helps show where Yasutoshi Koga may publish in the future.

Co-authorship network of co-authors of Yasutoshi Koga

This figure shows the co-authorship network connecting the top 25 collaborators of Yasutoshi Koga. A scholar is included among the top collaborators of Yasutoshi Koga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasutoshi Koga. Yasutoshi Koga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Photocatalytic Oxidative Dimerization of Electronically Diverse Phenols Using Borate to Prevent Overoxidation 2025 ·Journal of the American Chemical Society ·(unknown),Yasutoshi Koga,Gang Hong,Madeline E. Rotella,Marisa C. Kozlowski	0
2	Mitochondrial DNA depletion syndrome with a mutation in SLC25A4 developing epileptic encephalopathy: A case report 2021 ·Brain and Development ·(unknown),Jun Kido,Ken Momosaki,(unknown),Shiro Ozasa,Keiko Nomura,(unknown),Tomoko Tsuruoka,Kei Murayama,Yasutoshi Koga,Kimitoshi Nakamura	6
3	Temple syndrome diagnosed in an adult patient with clinical autism spectrum disorder 2018 ·Clinical Case Reports ·(unknown),Masayo Kagami,Keiko Matsubara,Shuichi Yatsuga,(unknown),(unknown),(unknown),Yasutoshi Koga	5
4	Therapeutic Regimen of L-arginine for Patients with MELAS: 9-year, Prospective, Multicentre, Clinical Research Integrating the Data from Two 2-year Clinical Trials with 7-year Follow-up (S54.008) 2018 ·Neurology ·Yasutoshi Koga,Nataliya Povalko,Eisuke Inoue,Hidefumi Nakamura,Akiko Ishii,Y. Suzuki,Makoto Yoneda,Fumio Kanda,Masaya Kubota,Hisashi Okada,Katsunori Fujii	1
5	Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial 2018 ·Journal of Neurology Neurosurgery & Psychiatry ·Yutaka Ohsawa,Hiroki Hagiwara,Shin‐ichiro Nishimatsu,Akihiro Hirakawa,Naomi Kamimura,Hideaki Ohtsubo,(unknown),T. Murakami,Yasutoshi Koga,Yu‐ichi Goto,Shigeo Ohta,Yoshihide Sunada	103
6	Phenotypic expression of a novel desmin gene mutation: hypertrophic cardiomyopathy followed by systemic myopathy 2017 ·Journal of Human Genetics ·Haruhito Harada,Takeharu Hayashi,Hirofumi Nishi,Ken Kusaba,Yoshinori Koga,Yasutoshi Koga,Ikuya Nonaka,Akinori Kimura	21
7	A Case of ACTH Resistance with Generalized Hyperpigmentation at Birth 2015 ·(unknown),Naoko Amano,Satoshi Narumi,Tomonobu Hasegawa,(unknown),(unknown),Shuichi Yatsuga,Yasutoshi Koga	0
8	Cdk5rap1-Mediated 2-Methylthio Modification of Mitochondrial tRNAs Governs Protein Translation and Contributes to Myopathy in Mice and Humans 2015 ·Cell Metabolism ·Fan‐Yan Wei,Bo Zhou,Takeo Suzuki,Keishi Miyata,Yoshihiro Ujihara,Haruki Horiguchi,Nozomu Takahashi,Peiyu Xie,Hiroyuki Michiue,Atsushi Fujimura,Taku Kaitsuka,Hideki Matsui,Yasutoshi Koga,Satoshi Mohri,Tsutomu Suzuki,Yuichi Oike,Kazuhito Tomizawa	84
9	Growth Differentiation Factor 15 and Fibroblast Growth Factor 21: Novel Biomarkers for Mitochondrial Diseases 2014 ·Shuichi Yatsuga,Yasutoshi Koga	1
10	A two-day-old hyperthyroid neonate with thyroid hormone resistance born to a mother with well-controlled Graves’ disease: a case report 2012 ·Journal of Medical Case Reports ·Shuichi Yatsuga,Yuji Hiromatsu,Shigekazu Sasaki,Hirotoshi Nakamura,(unknown),Junko Nishioka,Yasutoshi Koga	4
11	MELAS: A nationwide prospective cohort study of 96 patients in Japan 2011 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Shuichi Yatsuga,Nataliya Povalko,Junko Nishioka,(unknown),(unknown),Toyojiro Matsuishi,Tatsuyuki Kakuma,Yasutoshi Koga	197
12	Extensive screening system using suspension array technology to detect mitochondrial DNA point mutations 2010 ·Mitochondrion ·Yutaka Nishigaki,Hitomi Ueno,Jorida Çoku,Yasutoshi Koga,Tatsuya Fujii,Ko Sahashi,Kazutoshi Nakano,Makoto Yoneda,Michiko Nonaka,Lin-ya Tang,Chia‐Wei Liou,Véronique Paquis‐Flucklinger,Yasuo Harigaya,Tohru Ibi,Yu‐ichi Goto,Hiroko Hosoya,Salvatore DiMauro,Michio Hirano,Masashi Tanaka	24
13	MELAS and l‐arginine therapy: pathophysiology of stroke‐like episodes 2010 ·Annals of the New York Academy of Sciences ·Yasutoshi Koga,Nataliya Povalko,Junko Nishioka,Koujyu Katayama,(unknown),Toyojiro Matsuishi	78
14	Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency 2009 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Hirofumi Komaki,Yutaka Nishigaki,Noriyuki Fuku,Hiroko Hosoya,Kei Murayama,Akira Ohtake,Yu‐ichi Goto,Hiroyuki Wakamoto,Yasutoshi Koga,Masashi Tanaka	21
15	Ritodrine pharmacokinetics in twin pregnancy patients 2007 ·European Journal of Clinical Pharmacology ·(unknown),(unknown),(unknown),Yasutoshi Koga,Hiroshi Yoshida,(unknown),Tõru Hayakawa,Nobuo Inotsume	6
16	Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage 2006 ·Mitochondrion ·Hiroko P. Indo,Mercy M. Davidson,Hsiu‐Chuan Yen,Shigeaki Suenaga,Kazuo Tomita,Takeshi Nishii,Masahiro Higuchi,Yasutoshi Koga,Toshihiko Ozawa,Hideyuki J. Majima	427
17	COMPARISON OF THE RELAXANT EFFECTS OF DIAZEPAM, FLUNITRAZEPAM AND MIDAZOLAM ON AIRWAY SMOOTH MUSCLE 1992 ·British Journal of Anaesthesia ·Yasutoshi Koga,Ai Sato,(unknown),Masaki Takahashi,Masaki Kato,Naofumi Iwatsuki,Yosuke Hashimoto	32
18	Chronic progressive external ophthalmoplegia: A correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies 1990 ·Journal of the Neurological Sciences ·Yu‐ichi Goto,Yasutoshi Koga,Satoshi Horai,Ikuya Nonaka	88
19	Muscle pathology in cytochromec oxidase deficiency 1988 ·Acta Neuropathologica ·Ikuya Nonaka,Yasutoshi Koga,(unknown),Masanori Kobayashi,Naruji Sugiyama,(unknown),Ken‐ichi Nihei,(unknown),Masaya Segawa	28
20	Inhibition of Mitochondrial Functions by Margosa Oil: Possible Implications in the Pathogenesis of Reye's Syndrome 1987 ·Pediatric Research ·Yasutoshi Koga,Ichiro Yoshida,Akihiko Kimura,Makoto Yoshino,Fumiyoshi Yamashita,D. Sinniah	11

About Yasutoshi Koga

Yasutoshi Koga is a scholar working on Clinical Biochemistry, Molecular Biology and Rheumatology, having authored 204 papers that have together received 8.8k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (62 papers), Metabolism and Genetic Disorders (43 papers) and Diamond and Carbon-based Materials Research (28 papers). The work is most often cited by research in Clinical Biochemistry (3.1k citations), Molecular Biology (5.8k citations) and Aging (61 citations). Yasutoshi Koga has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Eric A. Schon, Mercy M. Davidson, Michael P. King, Salvatore DiMauro, Ikuya Nonaka, Shuichi Yatsuga, Michio Hirano, Massimo Zeviani, Toyojiro Matsuishi and Nataliya Povalko. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact